The origin and evolution of mutations in acute myeloid leukemia

Welch, John S., Ley, Timothy J., Link, Daniel C., Miller, Christopher A., Larson, David E., Koboldt, Daniel C., Wartman, Lukas D., Lamprecht, Tamara L. +46 more·2012·Cell

Cited by (1,001)

Items 401–500 of 1,001

  1. Next‐generation sequencing – feasibility and practicality in haematology
    Alexander Kohlmann, Vera Großmann, Niroshan Nadarajah, Torsten Haferlach · 2013 · British Journal of Haematology
  2. Gene mutations of acute myeloid leukemia in the genome era
    Tomoki Naoe, Hitoshi Kiyoi · 2013 · International Journal of Hematology
  3. The Biology and Targeting of FLT3 in Pediatric Leukemia
    Colleen Annesley, Patrick Andrew Brown · 2014 · Frontiers in Oncology
  4. Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation
    Chiara Brambati, Silvia Galbiati, Elisabetta Xue, Cristina Toffalori, Lara Crucitti, Raffaella Greco, Elisa Sala, Alessandra Crippa, Lorenza Chiesa, Nadia Soriani et al. · 2015 · Haematologica
  5. Whole‐exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia
    Norio Shiba, Kenichi Yoshida, Yuichi Shiraishi, Yusuke Okuno, Genki Yamato, Yusuke Hara, Yasunobu Nagata, Kenichi Chiba, Hiroko Tanaka, Kiminori Terui et al. · 2016 · British Journal of Haematology
  6. Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions
    Katharina Rothe, Vanessa Porter, Xiaoyan Jiang · 2019 · International Journal of Molecular Sciences
  7. Concise Review: Preleukemic Stem Cells: Molecular Biology and Clinical Implications of the Precursors to Leukemia Stem Cells
    Ashley Pandolfi, Laura Barreyro, Ulrich G. Steidl · 2013 · Stem Cells Translational Medicine
  8. The evolution of the unstable cancer genome
    Rebecca A. Burrell, Charles Swanton · 2014 · Current Opinion in Genetics & Development
  9. Toward precision medicine of breast cancer
    Nicolas Carels, Lizânia Borges Spinassé, Tatiana Martins Tilli, Jack A. Tuszyński · 2016 · Theoretical Biology and Medical Modelling
  10. The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9
    Joseph B. Fisher, J Peterson, Michael H. Reimer, Cary T. Stelloh, Kirthi Pulakanti, Zachary J. Gerbec, Alex M. Abel, Jennifer Strouse, Christopher Sun Strouse, Maureen McNulty et al. · 2016 · Leukemia
  11. Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
    Natarajan, Pradeep, Jaiswal, Siddhartha, Kathiresan, Sekar · 2018 · Circulation Genomic and Precision Medicine
  12. Cohesin gene mutations in tumorigenesis: from discovery to clinical significance
    David A. Solomon, Jung-Sik Kim, Todd A. Waldman · 2014 · BMB Reports
  13. Microfluidics for single-cell genetic analysis
    Alison M. Thompson, Amy L. Paguirigan, Jason E. Kreutz, Jerald P. Radich, Daniel T. Chiu · 2014 · Lab on a Chip
  14. Resilient and resourceful: Genome maintenance strategies in hematopoietic stem cells
    Sietske T. Bakker, Emmanuelle A. Passegue · 2013 · Experimental Hematology
  15. Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations
    Sergey I. Nikolaev, Marco Garieri, Federico Andrea Santoni, Emilie Falconnet, Pascale Ribaux, Michel Guipponi, Aoife Murray, Jürgen Groet, Emanuela Giarin, Giuseppe Basso et al. · 2014 · Nature Communications
  16. Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states
    Lukasz P. Gondek, Amy Elizabeth Dezern · 2019 · The Lancet Haematology
  17. Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes
    Jasmine A. McQuerry, Jeffrey T. Chang, David D.L. Bowtell, Adam Louis Cohen, Andrea H. Bild · 2017 · Journal of Molecular Medicine
  18. The crossroads between cancer stem cells and aging
    Sara Santos Franco, Hadas Raveh-Amit, Julianna Kobolák, Mohammed H Al-Qahtani, Ali Mobasheri, András Dinnyés · 2015 · BMC Cancer
  19. Organ-Specific Microenvironment Modifies Diverse Functional and Phenotypic Characteristics of Leukemia-Associated Macrophages in Mouse T Cell Acute Lymphoblastic Leukemia
    Sha-Yan Chen, Xiao Qi Yang, Wenli Feng, Jinfeng Liao, Lina Wang, Li Feng, Yong‐Min Lin, Qian Ren, Guoguang Zheng · 2015 · The Journal of Immunology
  20. Diagnostic Cancer Genome Sequencing and the Contribution of Germline Variants
    Outi Kilpivaara, Lauri A. Aaltonen · 2013 · Science
  21. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition
    L Chen, Wei Chen, Maria Mysliwski, Justin Serio, James P. Ropa, Fardokht A. Abulwerdi, Rebecca J. Chan, Jay P. Patel, Martin S. Tallman, Elisabeth M. Paietta et al. · 2015 · Leukemia
  22. Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo
    Daniel Klevebring, Gustaf Rosin, Ran Ma, Johan Lindberg, Kamila Czene, Juha Kere, Irma Fredriksson, Jonas C. S. Bergh, Johan Hartman · 2014 · Breast Cancer Research
  23. ASXL1 mutation in clonal hematopoiesis
    Takeshi Fujino, Toshio Kitamura · 2020 · Experimental Hematology
  24. The role of mutations in epigenetic regulators in myeloid malignancies
    Brittany A. Woods, Ross L. Levine · 2014 · Immunological Reviews
  25. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction
    Angeliki Thanasopoulou, Alexandar Tzankov, Juerg Schwaller · 2014 · Haematologica
  26. Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
    Jasper Hsu, Andreea Reilly, Brian J. Hayes, Courtnee A. Clough, Eric Quentin Konnick, Beverly Torok‐Storb, Süleyman Gülsüner, David Wu, Pamela Sue Becker, Sioḃán Keel et al. · 2019 · Blood
  27. Acute Myeloid Leukemia: Aging and Epigenetics
    Polina Zjablovskaja, Maria Carolina Florian · 2019 · Cancers
  28. Evolutionary trajectories of hyperdiploid ALL in monozygotic twins
    Caroline M. Bateman, Donát Alpár, Anthony M. Ford, S M Colman, Dörte Wren, M Morgan, L Kearney, Melvyn F. Greaves · 2014 · Leukemia
  29. Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
    Younguk Sun, Bo-Rui Chen, Aniruddha J. Deshpande · 2018 · Frontiers in Oncology
  30. The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia
    Ayşegül Erdem, Silvia Marín, Diego A. Pereira‐Martins, Roldán Cortés, Alan Cunningham, Maurien G. M. Pruis, Bauke de Boer, Fiona A.J. van den Heuvel, Marjan Geugien, Albertus T.J. Wierenga et al. · 2022 · Nature Communications
  31. Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AML
    Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard John Jones, Anurag K. Singh, Mark Robert Litzow, John R. Wingard, Esperanza Bouza Papadopoulos, Alexander E. Perl, Robert J. Soiffer et al. · 2025 · Blood
  32. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
    Anna Eriksson, Andreas Lennartsson, Sören Lehmann · 2015 · Experimental Hematology
  33. Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel
    Bradford W. Coffee, Hannah C. Cox, John Kidd, Scott Sizemore, Krystal L. Brown, Susan Manley, Debora Mancini‐DiNardo · 2017 · Cancer Genetics
  34. Coexisting and cooperating mutations in NPM1 -mutated acute myeloid leukemia
    Jay L. Patel, Jonathan A. Schumacher, Kimberly Frizzell, Shelly Sorrells, Wei Shen, Adam L. Clayton, Rakhi P. Jattani, Todd W. Kelley · 2017 · Leukemia Research
  35. Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia
    Brooks A. Benard, Logan B. Leak, Armon Azizi, Danièl Thomas, Andrew J. Gentles, Ravindra Majeti · 2021 · Nature Communications
  36. The evolving molecular genetic landscape in acute myeloid leukaemia
    Mathijs Arnoud Sanders, Peter J.M. Valk · 2013 · Current Opinion in Hematology
  37. Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis
    Jennifer Myers SanMiguel, Kira A. Young, Jennifer J. Trowbridge · 2020 · Experimental Hematology
  38. The multifaceted roles of cohesin in cancer
    Maddalena Di Nardo, Maria Michela Pallotta, Antonio Musio · 2022 · Journal of Experimental & Clinical Cancer Research
  39. Genomic landscape of CD34 + hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers
    Lan ping Xu, Zhaohui Gu, Yang Li, Jin-Li Zhang, Chunkang Chang, Chun‐Ming Pan, Jingyi Shi, Yang Shen, Bing Chen, Yueying Wang et al. · 2014 · Proceedings of the National Academy of Sciences
  40. The variety of leukemic stem cells in myeloid malignancy
    Daniel H Wiseman, Brigit F. Greystoke, T. Somervaille · 2014 · Oncogene
  41. TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity
    Tomoya Muto, María Guillamot, Jennifer Yeung, Jing Fang, Joshua R. Bennett, Bettina Nadorp, Audrey Lasry, Luna Zea-Redondo, Kwangmin Choi, Yixiao Gong et al. · 2022 · Cell stem cell
  42. The rarity of ALDH + cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients
    Van Thanh Hoang, Eike C. Buss, Wenwen Wang, Isabel Hoffmann, Simon Raffel, Abraham Zepeda‐Moreno, Natalia Baran, Patrick Wuchter, Volker Eckstein, Andreas Trumpp et al. · 2014 · International Journal of Cancer
  43. Stem Cell-Specific Mechanisms Ensure Genomic Fidelity within HSCs and upon Aging of HSCs
    Bettina Moehrle, Kalpana Nattamai, Andreas Brown, Maria Carolina Florian, Marnie A. Ryan, Mona Vogel, Corinna Bliederhaeuser, Karin Soller, Daniel R. Prows, Amir Abdollahi et al. · 2015 · Cell Reports
  44. Classic and Variants APLs, as Viewed from a Therapy Response
    Marie‐Claude Geoffroy, Hugues de Thé · 2020 · Cancers
  45. ‘CHIP’ping away at clonal hematopoiesis
    Daniel C. Link, Matthew J. Walter · 2016 · Leukemia
  46. DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
    Hanae Sato, Justin C. Wheat, Ulrich G. Steidl, Keisuke Ito · 2016 · Frontiers in Oncology
  47. Acute myeloid leukemia in the vascular niche
    Christopher Ramin Cogle, Raphael C. Bosse, Takae M. Brewer, Yazan Migdady, Reza Shirzad, Kim Rosalie Kampen, Najmaldin Saki · 2015 · Cancer Letters
  48. Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study
    Ronan T Swords, Diana J. Azzam, Hassan Al‐Ali, Ines Lohse, Claude‐Henry Volmar, Justin M. Watts, Aymee Perez, Ana J. Rodriguez, Fernando Vargas, Roy M. Elias et al. · 2017 · Leukemia Research
  49. Myeloproliferative neoplasms: from origins to outcomes
    Jyoti Nangalia, Anthony Richard Green · 2017 · Hematology
  50. Precision medicine review: rare driver mutations and their biophysical classification
    Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng · 2019 · Biophysical Reviews
  51. STAG Mutations in Cancer
    Laura Romero‐Pérez, Didier Surdez, Erika Brunet, Olivier Delattre, Thomas G. P. Grünewald · 2019 · Trends in cancer
  52. Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing
    Stephen J. Salipante, Jonathan R. Fromm, Jay Shendure, Brent Lee Wood, David Wu · 2014 · Modern Pathology
  53. Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition
    Subarna Sinha, Danièl Thomas, Linda Chia‐Hui Yu, Andrew J. Gentles, Namyoung Jung, M. Ryan Corces, Steven M. Chan, Andreas Reinisch, Andrew P. Feinberg, David L. Dill et al. · 2014 · Blood
  54. Accumulation of DNA damage in the aged hematopoietic stem cell compartment
    Isabel Beerman · 2016 · Seminars in Hematology
  55. Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia
    Yussanne P. Ma, Sara E. Dobbins, Amy L. Sherborne, Daniel Chubb, Marta Galbiati, Giovanni Cazzaniga, Concetta Micalizzi, Rick G. Tearle, Amy L. Lloyd, Richard D Hain et al. · 2013 · Proceedings of the National Academy of Sciences
  56. What are we learning from the cancer genome?
    Eric A. Collisson, Raymond Jaihyun Cho, Joe W. Gray · 2012 · Nature Reviews Clinical Oncology
  57. Next Generation Sequencing of Acute Myeloid Leukemia: Influencing Prognosis
    Asad Muhammad Ilyas, Sultan Ahmad, Muhammad Faheem, Muhammad Imran Naseer, Taha Kumosani, Muhammad Hussain Al-Qahtani, Mamdooh Abdullah Gari, Farid Ahmed · 2015 · BMC Genomics
  58. Stochastic modeling indicates that aging and somatic evolution in the hematopoietic system are driven by non-cell-autonomous processes
    Andrii I. Rozhok, Jennifer L. Salstrom, James V. DeGregori · 2014 · Aging
  59. Re-Evaluating Clonal Dominance in Cancer Evolution
    Rebecca A. Burrell, Charles Swanton · 2016 · Trends in cancer
  60. New approaches to molecular monitoring in CML (and other diseases)
    Jerald P. Radich, Cecilia C.S. Yeung, David Wu · 2019 · Blood
  61. High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
    Vera Grossmann, Susanne Schnittger, Franziska Poetzinger, Alexander Kohlmann, A Stiel, Christiane Eder, Annette Fasan, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach · 2013 · Leukemia
  62. Phylogenetic reconstruction of myeloproliferative neoplasm reveals very early origins and lifelong evolution
    Nicholas Williams, Joe Lee, Luiza Moore, E. Joanna Baxter, James Hewinson, Kevin J. Dawson, Andrew H. Menzies, Anna L. Godfrey, Anthony Richard Green, Peter J. Campbell et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  63. DNA damage in aging, the stem cell perspective
    McNeely, Taylor, Leone, Michael, Yanai, Hagai, Beerman, Isabel · 2020 · Human Genetics
  64. Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia
    Satoshi Wakita, Hiroki Yamaguchi, T Ueki, Kensuke Usuki, Saiko Kurosawa, Yutaka Kobayashi, Eri Kawata, Kenji Tajika, Shinya Gomi, M Koizumi et al. · 2015 · Leukemia
  65. Genome instability of ageing stem cells—Induction and defence mechanisms
    Martin D. Burkhalter, K. Lenhard Rudolph, Tobias Sperka · 2015 · Ageing Research Reviews
  66. Toward a general evolutionary theory of oncogenesis
    Paul W. Ewald, Holly A. Swain Ewald · 2012 · Evolutionary Applications
  67. Inferring mutational timing and reconstructing tumour evolutionary histories
    Samra Turajlic, Nicholas McGranahan, Charles Swanton · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  68. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
    Felicitas R. Thol, Sabrina Klesse, Lea-Marie Köhler, Razif R. Gabdoulline, Arnold Kloos, Alessandro Liebich, M Wichmann, Anuhar Chaturvedi, Jana Fabisch, Verena I. Gaidzik et al. · 2016 · Leukemia
  69. B-cell tumor development in Tet2-deficient mice
    Enguerran Mouly, Hussein Ghamlouch, Véronique Della-Valle, Laurianne Scourzic, Cyril Quivoron, Damien Roos‐Weil, Patrycja Pawlikowska, Véronique Saada, M'boyba Khadija Diop, Cécile K. Lopez et al. · 2018 · Blood Advances
  70. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome
    Kenichiro Watanabe · 2018 · Pediatrics International
  71. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies
    Catherine Handy Marshall, Lukasz P. Gondek, Jun Luo, Emmanuel S. Antonarakis · 2022 · Cancer Research
  72. Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols
    Ingegerd Ivanov Öfverholm, Anh Nhi Tran, Mats Marshall Heyman, Vasilios Zachariadis, Magnus Nordenskjöld, Ann Nordgren, Gisela Barbany · 2013 · Leukemia
  73. Systems cell biology
    Fred David Mast, Alexander V. Ratushny, John D. Aitchison · 2014 · The Journal of Cell Biology
  74. Roles of IDH1/2 and TET2 mutations in myeloid disorders
    Satoshi Inoue, François Lemonnier, Tak W. Mak · 2016 · International Journal of Hematology
  75. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice
    Edwige Voisset, Eva Moravcsik, Eva Wessel Stratford, Amie Jaye, Christopher J. Palgrave, Robert Kerrin Hills, Paolo Salomoni, Scott C. Kogan, Ellen Solomon, David J. Grimwade · 2017 · Blood
  76. Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
    Ramona Bledea, Varshini Vasudevaraja, Seema V. Patel, James M. Stafford, Jonathan Serrano, Gianna Esposito, Lilian M. Tredwin, Nina E. Goodman, Andreas Kloetgen, John G. Golfinos et al. · 2019 · Scientific Reports
  77. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer
    Tae‐Min Kim, Seung‐Hyun Jung, I.-W. Baek, Sung‐Hak Lee, Youn‐Jin Choi, Ji‐Youl Lee, Chung Yeun‐Jun, Sug‐Hyung Lee · 2014 · The Journal of Pathology
  78. Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”
    Maxime Tarabichi, A. Antoniou, Manuel Saiselet, Jaime Miguel Gomes Pita, Guy Andry, J.E. Dumont, Vincent Detours, Carine Maenhaut · 2013 · Cancer and Metastasis Reviews
  79. The biology and clinical impact of genetic lesions in myeloid malignancies
    Robert Coleman Lindsley, Benjamin L. Ebert · 2013 · Blood
  80. Cohesin mutations in myeloid malignancies: underlying mechanisms
    Bryony J. Leeke, Judith Marsman, Justin Martin O'Sullivan, Julia A. Horsfield · 2014 · Experimental Hematology and Oncology
  81. Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow
    Étienne Paubelle, Florence Zylbersztejn, Thiago Trovati Maciel, Caroline Carvalho, Annalisa Mupo, Meyling Hua-Chen Cheok, Liesbet Lieben, Pierre Sujobert, Justine Decroocq, Akihiko Yokoyama et al. · 2020 · Cell Reports
  82. Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
    Alexandra S. Higgins, Mithun Vinod Shah · 2020 · Genes
  83. TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
    Binsah George, Hagop M. Kantarjian, Natalia Baran, Joseph D. Krocker, Adan A. Rios · 2021 · International Journal of Molecular Sciences
  84. The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation
    Arnold J. Levine, Anna M. Puzio‐Kuter, Chang S. Chan, Pierre L. Hainaut · 2016 · Cold Spring Harbor Perspectives in Medicine
  85. Mutant cohesin drives chromosomal instability in early colorectal adenomas
    Francesco Cucco, Adele Servadio, Veronica Gatti, Paolo Pietro Bianchi, Linda Mannini, Andrea Prodosmo, Elisa De Vitis, Gianluca Basso, Alessandro Friuli, Luigi Laghi et al. · 2014 · Human Molecular Genetics
  86. Sequencing-based measurable residual disease testing in acute myeloid leukemia
    Yoest, Jennifer M., Shirai, Cara Lunn, Duncavage, Eric J. · 2020 · Frontiers in Cell and Developmental Biology
  87. Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms
    Maria Linda Cruceru, Monica Teodora Neagu, Jean‐Baptiste Demoulin, Stefan N. Constantinescu · 2013 · Journal of Cellular and Molecular Medicine
  88. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection
    Vinod Kumar Yadav, James V. DeGregori, Subhajyoti De · 2016 · Nucleic Acids Research
  89. Epigenetics in normal and malignant hematopoiesis: An overview and update 2017
    Susumu Goyama, Toshio Kitamura · 2017 · Cancer Science
  90. PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML
    Tom Verbiest, Simon D Bouffler, Stephen L. Nutt, Christophe Badie · 2015 · Carcinogenesis
  91. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study
    Yasuhiko Harada, Yasunobu Nagata, Rika Kihara, Yuichi Ishikawa, Norio Asou, Shigeki Ohtake, Shuichi Miyawaki, Toru Sakura, Yukiyasu Ozawa, Noriko Usui et al. · 2018 · Leukemia Research
  92. Human leukemia mutations corrupt but do not abrogate GATA-2 function
    Koichi Ricardo Katsumura, Charu Mehta, Kyle J. Hewitt, Alexandra A. Soukup, Isabela Fraga de Andrade, Erik A. Ranheim, Kirby D. Johnson, Emery H. Bresnick · 2018 · Proceedings of the National Academy of Sciences
  93. The leukemia strikes back: a review of pathogenesis and treatment of secondary AML
    Edna Cheung, Anthony J. Perissinotti, Dale Lee Bixby, Patrick W. Burke, Kristen Marie Pettit, Lydia L. Benitez, Julia M. Brown, Gianni Bruno Scappaticci, Bernard Lawrence Marini · 2019 · Annals of Hematology
  94. Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
    Muhammad Nadeem Abbas, Saima Kausar, Hongjuan Cui · 2019 · Clinical & Translational Oncology
  95. Recent advances in dielectrophoresis‐based cell viability assessment
    Junyan Zhang, Zhenyu Song, Qinxin Liu, Yongxin Song · 2019 · Electrophoresis
  96. Clonal hematopoiesis, aging, and cardiovascular diseases
    Evangelia Pardali, Stefanie Dimmeler, Andreas Michael Zeiher, Michael A. Rieger · 2019 · Experimental Hematology
  97. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment
    Edoardo Peroni, Maria Luigia Randi, Antonio Rosato, Stefano Cagnin · 2023 · Journal of Experimental & Clinical Cancer Research
  98. Epigenetic alterations in acute myeloid leukemias
    Parinaz Mehdipour, Fabio Santoro, Saverio Minucci · 2014 · FEBS Journal
  99. A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues
    Benjamin Werner, David Dingli, Arne Traulsen · 2013 · Journal of The Royal Society Interface
  100. Aplastic anemia and clonal evolution: germ line and somatic genetics
    Akiko Shimamura · 2016 · Hematology